The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | COVID-19: European Research Initiative on CLL recommendations
Paolo Ghia, MD, PhD, Università Vita-Salute San Raffaele, Milan, Italy, discusses COVID-19 vaccination recommendations for patients with chronic lymphocytic leukemia (CLL) from the European Research Initiative on CLL (ERIC). Dr Ghia recommends that patients receive COVID-19 vaccinations prior to receiving therapy where possible, and that current precautions, such as wearing masks, should be maintained post-vaccination. This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
